|
Status |
Public on Jul 01, 2013 |
Title |
Pt34_Post |
Sample type |
RNA |
|
|
Source name |
Tumor
|
Organism |
Homo sapiens |
Characteristics |
timepoint: Post-Cediranib treatment
|
Extracted molecule |
total RNA |
Extraction protocol |
standard Affymetrix protocol
|
Label |
biotin
|
Label protocol |
Affymetrix GeneChip 3’ IVT Express Labeling Kit, manufacturer's protocol
|
|
|
Hybridization protocol |
Hybridization, staining, and scanning were performed in quadruplicate using the GeneChip Human Genome U133 Plus 2.0 Array (Affymetrix)
|
Scan protocol |
Affymetrix GeneChip Scanner 3000 according to the manufacturer’s protocol
|
Data processing |
Probe set summarization and normalization was performed by robust multi-array averaging (RMA, including background subtraction, summarization by median polish and quantile normalization) using the R/Bioconductor package affy.
|
|
|
Submission date |
Oct 03, 2011 |
Last update date |
Jul 01, 2013 |
Contact name |
Eric C Polley |
E-mail(s) |
[email protected]
|
Organization name |
National Cancer Institute
|
Department |
Biometric Research Branch
|
Street address |
9609 Medical Center Drive, Rm 5W118
|
City |
Bethesda |
State/province |
MD |
ZIP/Postal code |
20892 |
Country |
USA |
|
|
Platform ID |
GPL570 |
Series (1) |
GSE32569 |
Expression data for Cediranib in Metastatic ASPS |
|